NPCE
NPCE
NASDAQ · Health Care

Neuropace Inc

$8.32
+0.12 (+1.46%)
As of Nov 18, 8:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
109.82M
Net Income
-23,577,068
Gross Margin
77.2%
Profit Margin
-21.5%
Rev Growth
+30.0%
D/E Ratio
3.09
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 77.2% 77.2% 46.3% 46.3%
Operating Margin -16.8% -15.2% 8.2% 8.2%
Profit Margin -21.5% -20.4% 8.6% 7.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 109.82M 84.48M 354.79M 322.64M
Gross Profit 84.81M 65.25M 164.26M 149.37M
Operating Income -18,493,731 -12,804,337 29.06M 26.44M
Net Income -23,577,068 -16,323,841 30.47M 23.82M
Gross Margin 77.2% 77.2% 46.3% 46.3%
Operating Margin -16.8% -15.2% 8.2% 8.2%
Profit Margin -21.5% -20.4% 8.6% 7.4%
Rev Growth +30.0% +30.0% -3.6% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 98.05M 98.05M 135.86M 137.71M
Total Equity 31.69M 31.69M 359.61M 343.18M
D/E Ratio 3.09 3.09 0.38 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,232,693 -13,324,916 37.66M 35.61M
Free Cash Flow — — 33.72M 30.25M